Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn
Only remove the plastic flip-off cap, then cleanse the exposed rubber stopper with alcohol before each use
Biosci Biotechnol Biochem
AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys
This years 2026 American Society of Clinical Oncology (ASCO) Annual Meeting revealed two such studies
So far, serious side effects havent been common, but heres what an early phase 2 study has shown: Pancreatitis: Happened in about 0.4% of people in the study Gallbladder problems: Reported in about 1.1% of participants Heart rhythm changes: Seen more often with retatrutide, about 6% compared to 3% with placebo Liver enzyme changes: Around 1% of participants had increases, but overall liver health stayed stable These results suggest a low but real chance of serious issues such as pancreatitis, gallbladder problems, severe GI events, and allergic reactions
